Evaluating Modes of Influenza Transmission (EMIT-2): Insights from a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT).
Saved in:
| Title: | Evaluating Modes of Influenza Transmission (EMIT-2): Insights from a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT). |
|---|---|
| Authors: | Lai J; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Sobhani H; Department of Mechanical Engineering, University of Maryland, College Park, MD, USA., Coleman KK; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Tai SS; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Hong F; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Maldonado IS; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Esparza Y; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., McPhaul KM; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA., Zhu S; Department of Mechanical Engineering, University of Maryland, College Park, MD, USA., DeVoe DL; Department of Mechanical Engineering, University of Maryland, College Park, MD, USA.; Fischell Institute for Biomedical Devices, University of Maryland, College Park., Ortiz JR; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Chen S; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA., Yellin T; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Carreno JM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria., Cowling BJ; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, China., Gordon A; School of Public Health, University of Michigan, Ann Arbor, MI, USA., Chen WH; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Srebric J; Department of Mechanical Engineering, University of Maryland, College Park, MD, USA., Milton DK; Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, MD, USA.; Fischell Institute for Biomedical Devices, University of Maryland, College Park. |
| Source: | MedRxiv : the preprint server for health sciences [medRxiv] 2025 Dec 02. Date of Electronic Publication: 2025 Dec 02. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
